Oryzon Genomics S.A. (0RDB.L)

EUR 1.6

(-4.88%)

Total Assets Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual total assets in 2023 was 118.01 Million USD , up 6.28% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly total assets in 2024 Q2 was 118.55 Million USD , down 0.0% from previous quarter.
  • Oryzon Genomics S.A. reported annual total assets of 111.03 Million USD in 2022, up 2.28% from previous year.
  • Oryzon Genomics S.A. reported annual total assets of 108.56 Million USD in 2021, down -5.56% from previous year.
  • Oryzon Genomics S.A. reported quarterly total assets of 114.18 Million USD for 2023 Q2, down 0.0% from previous quarter.
  • Oryzon Genomics S.A. reported quarterly total assets of 118.01 Million USD for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Oryzon Genomics S.A. (2023 - 2012)

Historical Annual Total Assets of Oryzon Genomics S.A. (2023 - 2012)

Year Total Assets Total Assets Growth
2023 118.01 Million USD 6.28%
2022 111.03 Million USD 2.28%
2021 108.56 Million USD -5.56%
2020 114.96 Million USD 27.96%
2019 89.84 Million USD 16.27%
2018 77.27 Million USD 5.51%
2017 73.23 Million USD 39.88%
2016 52.35 Million USD 18.36%
2015 44.23 Million USD 40.25%
2014 31.54 Million USD -20.37%
2013 39.6 Million USD 0.0%
2012 - USD 0.0%

Peer Total Assets Comparison of Oryzon Genomics S.A.

Name Total Assets Total Assets Difference
Boiron SA 590.2 Million EUR 80.004%
Laboratorios Farmaceuticos Rovi, S.A. 799.88 Million EUR 85.246%
Vetoquinol SA 692.23 Million EUR 82.951%
Valneva SE 469.39 Million EUR 74.857%
AB Science S.A. 25.49 Million EUR -362.831%
Nanobiotix S.A. 93.89 Million EUR -25.688%
PHAXIAM Therapeutics S.A. 51.3 Million EUR -130.022%
Vivoryon Therapeutics N.V. 30.82 Million EUR -282.813%
BioSenic S.A. 9.55 Million EUR -1134.62%
ABIVAX Société Anonyme 327.06 Million EUR 63.916%
Formycon AG 890.36 Million EUR 86.745%